New results from the Phase III MATTERHORN trial show AstraZeneca’s Imfinzi combination reduced the risk of death by 22% ...

Edwards also noted the shift towards adaptive trial designs and the benefits of staying with the same CRO for continuity.

Praxis Precision Medicines has shared positive data from its Phase III Essential3 clinical trial program (NCT06087276) assessing ulixacaltamide in essential tremor (ET). Across two studies, the small ...

Gain insight into why early toxicology readiness and strong scientific collaboration with CRO partners are critical to ...

Designing adhesion and durability for biopharmaceuticals in the most extreme cold chain environments.

Take a closer look at how agentic AI can automate repetitive monitoring tasks while keeping human oversight central to ...

Understand how intelligent study design, focused data collection, and faster analytics can help clinical teams deliver meaningful results that sustain investor momentum.

This is the Applied Clinical Trials Brief —your fast track to the latest insights in clinical research operations. In under ...

Gain perspective on how agentic AI can bridge eCOA, EDC, IRT, and CTMS platforms to reduce manual effort and improve ...

Eli Lilly’s oral GLP-1 therapy, orforglipron, met all primary and key secondary endpoints in the Phase III ACHIEVE-2 and ACHIEVE-5 studies, showing significant A1C reduction, weight loss, and ...

Uncover how improving data accuracy and leveraging synthetic control arms can optimize trial efficiency, reduce costs, and ...

Understand how intelligent study design, focused data collection, and faster analytics can help clinical teams deliver meaningful results that sustain investor momentum. Gain insight into why early ...